453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study

T. Doi, Minesh Patel, G.S. Falchook, T. Koyama, C.F. Friedman, S. Piha-Paul, M.E. Gutierrez, R. Abdul-Karim, M. Awad, D.R. Adkins, S. Takahashi, S. Kadowaki, B. Cheng, N. Ikeda, A. Laadem, N. Yoshizuka, M. Qian, O. Dosunmu, H-T. Arkenau, M.L. Johnson